documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
8 rows where agency_id = "FDA" and document_type = "Other" sorted by comment_end_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, comment_start_date, comment_end_date, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
agency_id 1
- FDA · 8 ✖
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date ▲ | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2026-P-0749-0001 | FDA | FDA-2026-P-0749 | Citizen Petition from Apotex Inc. | Other | Citizen Petition | 2026-01-26 | 2026 | 1 | 2026-01-26 | 2026-07-23 | 2026-05-08 20:03:22 | 1 | 0 | 09000064b9182c73 | |
| FDA-2026-D-1255-0002 | FDA | FDA-2026-D-1255 | Safety Assessment of Genome Editing in Human Gene Therapy Products Using Next-Generation Sequencing; Draft Guidance for Industry | Other | Guidance | 2026-04-15 | 2026 | 4 | 2026-04-15 | 2026-07-15 | 2026-05-15 09:00:20 | 1 | 0 | 09000064b9282a2a | |
| FDA-2025-D-6130-0002 | FDA | FDA-2025-D-6130 | Establishing Impurity Specifications for Antibiotics; Draft Guidance for Industry | Other | Guidance | 2026-04-20 | 2026 | 4 | 2026-04-20 | 2026-06-23 | 2026-04-28 09:00:28 | 1 | 0 | 09000064b92940ac | |
| FDA-2025-D-7121-0002 | FDA | FDA-2025-D-7121 | Compliance Policy Regarding Premarket and Other Requirements for Certain NIOSH Approved Air-Purifying Respirators; Draft Guidance for Industry and Food and Drug Administration Staff | Other | Guidance | 2026-04-20 | 2026 | 4 | 2026-04-20 | 2026-06-23 | 2026-05-06 09:00:15 | 1 | 0 | 09000064b928d63f | |
| FDA-2021-D-0613-0003 | FDA | FDA-2021-D-0613 | Stability Testing for Medicated Premixes (Revision 1); VICH GL8(R); Guidance for Industry; Draft Guidance; #91 | Other | Guidance | 2026-04-16 | 2026 | 4 | 2026-04-16 | 2026-06-16 | 2026-04-16 20:09:33 | 1 | 0 | 09000064b9287b2e | |
| FDA-2025-D-2837-0002 | FDA | FDA-2025-D-2837 | Questions and Answers About Requirements for Additional Traceability Records for Certain Foods: Guidance for Industry - Draft Guidance | Other | Guidance | 2026-02-20 | 2026 | 2 | 2026-02-20 | 2026-05-22 | 2026-02-20 20:47:16 | 1 | 0 | 09000064b91c9d9a | |
| FDA-2026-N-1304-0001 | FDA | FDA-2026-N-1304 | Agenda for the U.S. Food and Drug Administration (FDA) Virtual Public Meeting Food Allergen Thresholds and Their Potential Applications 2-18-2026 | Other | Agenda | 2026-02-18 | 2026 | 2 | 2026-02-18 | 2026-05-20 | 2026-05-17 09:00:21 | 1 | 0 | 09000064b91b5eeb | |
| FDA-2025-D-6131-0002 | FDA | FDA-2025-D-6131 | General Considerations for the Use of New Approach Methodologies in Drug Development; Guidance for Industry - Draft Guidance | Other | Guidance | 2026-03-19 | 2026 | 3 | 2026-03-19 | 2026-05-19 | 2026-05-16 09:00:11 | 1 | 0 | 09000064b9223609 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT,
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date);
CREATE INDEX idx_docs_withdrawn ON documents(withdrawn);
document_type 1